Antihypertensive drugs classification
Pro Research Analysisby 
Searched over 200M research papers
Classification of Antihypertensive Drugs
Introduction to Antihypertensive Drug Classes
Antihypertensive drugs are essential in managing hypertension, a condition that significantly increases the risk of cardiovascular diseases. These drugs are classified into several pharmacological classes based on their mechanisms of action and side effects. The primary classes include beta-blockers, diuretics, angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin II receptor blockers (ARBs), and calcium channel blockers (CCBs).
Major Classes of Antihypertensive Drugs
Beta-Blockers
Beta-blockers work by blocking the effects of adrenaline on the heart, reducing heart rate and blood pressure. They are effective in lowering blood pressure but are less favored due to their higher rate of treatment discontinuation compared to other classes. Beta-blockers are also associated with an increased risk of adverse events, making them less acceptable for long-term use.
Diuretics
Diuretics help the kidneys remove excess sodium and water from the body, reducing blood volume and pressure. They are effective in lowering blood pressure but have a higher incidence of adverse events leading to treatment discontinuation. Despite their effectiveness, diuretics are often associated with a higher risk of developing diabetes compared to other antihypertensive drugs.
ACE Inhibitors
ACE inhibitors prevent the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. They are effective in reducing blood pressure and preventing major cardiovascular events. However, ACE inhibitors are associated with a higher rate of treatment discontinuation due to adverse events compared to ARBs and CCBs. They are also contraindicated in pregnant women due to potential teratogenic effects.
Angiotensin II Receptor Blockers (ARBs)
ARBs block the action of angiotensin II, leading to vasodilation and reduced blood pressure. They are highly effective in reducing blood pressure and preventing cardiovascular events. ARBs have the lowest rate of treatment discontinuation due to adverse events, making them highly acceptable for long-term use. They are also associated with a lower risk of developing diabetes compared to other antihypertensive drugs.
Calcium Channel Blockers (CCBs)
CCBs prevent calcium from entering the cells of the heart and blood vessel walls, leading to vasodilation and reduced blood pressure. They are effective in reducing blood pressure and preventing cardiovascular events. CCBs have a favorable acceptability profile, with a lower rate of treatment discontinuation compared to beta-blockers and ACE inhibitors. They are also effective in reducing interindividual variation in blood pressure, which is beneficial in stroke prevention.
Additional Classes of Antihypertensive Drugs
Renin Inhibitors
Renin inhibitors block the activity of renin, an enzyme involved in the production of angiotensin I. They are effective in lowering blood pressure but are less commonly used due to limited evidence on their long-term benefits and higher rates of adverse events.
Alpha-Adrenergic Receptor Blockers
Alpha-blockers reduce blood pressure by blocking alpha-adrenergic receptors, leading to vasodilation. They are effective but are associated with a higher rate of treatment discontinuation due to adverse events.
Centrally Acting Agents
These drugs act on the central nervous system to reduce sympathetic outflow, leading to lower blood pressure. They are effective but are often associated with significant side effects, leading to higher rates of treatment discontinuation.
Direct-Acting Vasodilators
Direct-acting vasodilators relax the smooth muscles of blood vessels, leading to vasodilation and reduced blood pressure. They are effective but are typically used in combination with other antihypertensive drugs due to their side effects.
Conclusion
The classification of antihypertensive drugs is essential for selecting the most appropriate treatment for patients with hypertension. While all classes are effective in lowering blood pressure, their side effects and acceptability profiles vary significantly. ARBs and CCBs are generally preferred due to their lower rates of adverse events and higher acceptability, making them suitable for long-term use . Understanding these differences helps in tailoring hypertension treatment to individual patient needs, improving outcomes and adherence to therapy.
Sources and full results
Most relevant research papers on this topic